First dose of gene therapy given

Yesterday the first dose of the gene therapy product was given as part of the pilot study. The pilot study involves 27 people with CF taking one dose each and following successful results of the pilot study, we will move towards the major multi-dose clinical trial. It has taken a great deal of time, effort and money on behalf of us all at the CF Trust, the UK CF Gene Therapy Consortium and the CF community to get this far, so although there is still a great deal of work to be done, we are very excited to reach this stage.